Director at COMMUNITY HEALTH SYSTEMS (CYH) granted 52,023 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

JENNINGS WILLIAM NORRIS reported acquisition or exercise transactions in this Form 4 filing.

COMMUNITY HEALTH SYSTEMS INC director William Norris Jennings reported an award of restricted stock units. He received 52,023 Restricted Stock Units on March 1, 2026 as a grant at no cash cost. These units vest in three equal installments on the first, second, and third anniversaries of the grant date.

According to his prior deferral elections, the units will be settled in an equal number of Community Health Systems common shares when he ceases to be a director or on previously specified dates. After this award, he directly holds 275,271 restricted stock units and 78,468 shares of common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider JENNINGS WILLIAM NORRIS

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	52,023	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 275,271 shares (Direct); Common Stock — 78,468 shares (Direct)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

03/03/2026 - 04:39 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JENNINGS WILLIAM NORRIS

(Last)

(First)

(Middle)

4000 MERIDIAN BOULEVARD

(Street)

FRANKLIN

37067

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
COMMUNITY HEALTH SYSTEMS INC [ CYH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								78,468	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	03/01/2026		A		52,023		⁽¹⁾	⁽¹⁾	Common Stock	52,023	$0	275,271	D

Explanation of Responses:

1. These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

	Christopher G. Cobb, Attorney in Fact for William Norris Jennings	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CYH director William Norris Jennings report?

CYH director William Norris Jennings reported receiving 52,023 restricted stock units as an equity award. The grant was made at no cash cost to him and vests over three years, adding to his existing restricted stock unit and common share holdings.

How many restricted stock units did CYH grant to director Jennings?

CYH granted Jennings 52,023 restricted stock units as a new award. These units vest in three equal installments on the first, second, and third anniversaries of the March 1, 2026 grant date, subject to the terms of the award agreement and his service.

When do William Norris Jennings’ CYH restricted stock units vest and settle?

The 52,023 CYH restricted stock units vest in one-third increments on the first, second and third anniversaries of March 1, 2026. Settlement into CYH common shares occurs when he ceases as a director or on specific dates he previously elected under the award terms.

How many CYH restricted stock units does Jennings hold after this Form 4?

After this grant, Jennings directly holds 275,271 restricted stock units of CYH. This total includes the newly awarded 52,023 units and reflects his aggregate restricted stock unit position as reported following the March 1, 2026 transaction in the filing.

How many CYH common shares does Jennings directly own after the reported transactions?

Following the reported transactions, Jennings directly owns 78,468 shares of CYH common stock. This figure reflects his common stock holdings after the March 1, 2026 activity, separate from his 275,271 restricted stock units that will later settle into additional common shares.

Did Jennings pay cash for the 52,023 CYH restricted stock units?

No, Jennings did not pay cash for the 52,023 restricted stock units; the transaction price per unit is reported as 0.0000. The award represents an equity grant from CYH, subject to vesting and later share settlement under the award agreement.